Visit the Osiris Therapeutics, Inc. website
Osiris Therapeutics, Inc., based in Columbia, MD, is a leader in researching, developing, and marketing cellular regenerative medicine products that improve the health and lives of patients and lower overall health-care costs. Having developed the world’s first approved stem cell drug, Osiris works to further advance the medical field. Osiris’ research and development in biotechnology focuses on innovation in regenerative medicine, including bioengineering, stem cell research, and viable tissue-based products. Osiris has achieved commercial success with products in orthopedics, sports medicine, and wound care, including BIO4®, a viable bone matrix; Cartiform®, a viable osteochondral allograft; Grafix®, a cryopreserved placental membrane; TruSkin™, a viable human skin allograft; and Stravix™, a durable placental allograft.